乳房生検装置市場：製品、検査、ガイダンス、最終用途別-2025年～2030年の世界予測

乳房生検装置市場は、2023年に9億9,844万米ドルと評価され、2024年には11億462万米ドルに達すると予測され、CAGR 10.72%で成長し、2030年には20億3,769万米ドルに達すると予測されています。

乳房生検装置市場には、乳がんやその他の異常の診断検査のために乳房組織サンプルを抽出するためのツールや機器が含まれます。これらの機器は、乳がんの診断や病期分類に不可欠であり、患者のケアにおける極めて重要なステップです。乳がんの有病率の増加と技術の進歩に後押しされ、低侵襲で正確な診断ソリューションへの需要が高まっています。コアニードル生検、真空支援生検、細針吸引は、病院、診断センター、外来手術センター向けの主要なアプリケーションのひとつです。自動生検システムや画像誘導生検システムなどの技術的進歩に加え、乳がん検診に対する意識の高まりや検診プログラムの増加が成長を後押ししています。アジア太平洋とラテンアメリカの新興市場は、ヘルスケア支出の増加と医療施設の近代化により有望な機会を提供しています。しかしながら、先進生検装置の高価格、規制上のハードル、高度な機械を操作する熟練した専門家の不足などが障壁となっています。これらの要因は市場の成長を阻害する可能性があります。技術革新の機会は、データ管理や遠隔医療支援のためのデジタルヘルス統合とともに、費用対効果が高く、より小型で、より精密な装置の開発にあります。トレーニングや啓発のためのヘルスケアプロバイダーとのコラボレーションは、採用をさらに促進する可能性があります。市場は競争が激しく、主要企業は優位性を維持するために継続的に研究開発に投資しています。人工知能や機械学習などの新技術を開発することで、診断精度と効率を向上させたよりスマートな生検ツールが実現する可能性があります。このようなビジネスチャンスを生かすため、企業は戦略的パートナーシップと地理的拡大に注力し、規制と償還の課題に対処しながら未開拓の市場を開拓すべきです。リースなどの柔軟な購入モデルを提供することで、コスト障壁を緩和し、資源が限られた環境でのアクセシビリティを高めることもできます。市場の性質はダイナミックであり、急速な技術の進歩やヘルスケア情勢の変化により、競争力を維持するために継続的な適応が必要とされています。

市場力学：急速に進化する乳房生検装置市場の主要市場インサイトを公開

乳房生検装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の乳がん患者の増加
  • 乳がんに対する認識と治療に対する政府の取り組み
  • 乳がんの早期発見とスクリーニングに対する嗜好の変化
• 市場抑制要因
  • 生検針による感染の可能性
• 市場機会
  • 乳がん治療用リキッドバイオプシー機器の登場
  • 進行中の臨床試験と新製品開発の増加
• 市場の課題
  • 資金と技術資源の不足

ポーターの5つの力：乳房生検装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：乳房生検装置市場における外部からの影響の把握

外部マクロ環境要因は、乳房生検装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析乳房生検装置市場における競合情勢の把握

乳房生検装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス乳房生検装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、乳房生検装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨乳房生検装置市場における成功への道筋を描く

乳房生検装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で乳がんの症例が増加
    • 乳がんの啓発と治療のための政府の取り組み
    • 乳がんの早期発見とスクリーニングに対する好みの変化
  • 抑制要因
    • 生検針に関連する感染の可能性
  • 機会
    • 乳がん治療のための液体生検装置の登場
    • 進行中の臨床試験と新製品開発の増加
  • 課題
    • 資金と技術資源の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 乳房生検装置市場：製品別

• 生検針
• 生検テーブル
• 誘導システム
• ローカリゼーションワイヤー

第7章 乳房生検装置市場：検査別

• 針乳房生検
  • コア針吸引
  • 穿刺吸引法
  • 吸引コア生検
• 外科的生検
  • 乳房切除生検
  • 切開乳房生検

第8章 乳房生検装置市場：ガイダンス別

• 磁気共鳴誘導
• マンモグラフィー誘導定位放射線治療
• 超音波ガイド下

第9章 乳房生検装置市場：最終用途別

• 診断センター
• 病院・クリニック

第10章 南北アメリカの乳房生検装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の乳房生検装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの乳房生検装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advin Health Care
• Argon Medical Devices, Inc.
• Becton, Dickinson and Company
• Cook Group Incorporated
• Danaher Corporation
• FUJIFILM Corporation
• GE HealthCare Technologies Inc.
• Halma plc
• Hologic, Inc
• INRAD Inc.
• Medline Industries, LP
• Medtronic PLC
• Merit Medical Systems, Inc.
• Ningbo Xinwell Medical Technology Co., LTD.
• PAJUNK GmbH
• Planmeca Oy
• Point Blank Medical
• Siemens Healthcare GmbH
• SNVL Varay Laborix
• STERYLAB S.r.l.
• Suretech Medical Inc.
• Thermo Fisher Scientific Inc.
• Trivitron Healthcare
• Vector Medical, Inc.
• Zamar Care

LIST OF FIGURES

• FIGURE 1. BREAST BIOPSY DEVICE MARKET RESEARCH PROCESS
• FIGURE 2. BREAST BIOPSY DEVICE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BREAST BIOPSY DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BREAST BIOPSY DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE-NEEDLE ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE-NEEDLE ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED CORE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY INCISIONAL BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MAGNETIC RESONANCE-GUIDED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 50. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 51. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 52. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 82. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 83. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 84. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 85. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 88. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 89. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 90. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 91. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 189. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 191. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 192. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 193. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 194. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 213. POLAND BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. POLAND BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 215. POLAND BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 216. POLAND BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 217. POLAND BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 218. POLAND BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 219. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 221. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 222. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 223. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 224. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 279. BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 280. BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

The Breast Biopsy Device Market was valued at USD 998.44 million in 2023, expected to reach USD 1,104.62 million in 2024, and is projected to grow at a CAGR of 10.72%, to USD 2,037.69 million by 2030.

The breast biopsy device market encompasses tools and instruments used to extract breast tissue samples for diagnostic examination of breast cancer and other abnormalities. These devices are critical in diagnosing and staging breast cancer, representing a pivotal step in patient care. Driven by an increasing prevalence of breast cancer and advancements in technology, the demand for minimally invasive and accurate diagnostic solutions is increasing. Core needle biopsies, vacuum-assisted biopsies, and fine needle aspiration are among the primary applications, catering to hospitals, diagnostic centers, and ambulatory surgical centers. Growth is fueled by rising awareness and a growing number of breast cancer screening programs, alongside technological advancements such as automated and image-guided biopsy systems. Emerging markets in Asia-Pacific and Latin America offer promising opportunities due to increased healthcare spending and modernization of medical facilities. However, barriers include the high cost of advanced biopsy devices, regulatory hurdles, and a shortage of skilled professionals to operate sophisticated machinery. These factors can impede market growth. Opportunities for innovation lie in developing cost-effective, smaller, and more precise devices, along with digital health integration for data management and telemedicine support. Collaborations with healthcare providers for training and awareness can further enhance adoption. The market is competitive, with key players continuously investing in R&D to maintain their edge. Developing emerging technologies, such as artificial intelligence and machine learning, can lead to smarter biopsy tools with improved diagnostic accuracy and efficiency. To capitalize on these opportunities, businesses should focus on strategic partnerships and geographic expansion to tap into unexplored markets while addressing regulatory and reimbursement challenges. Offering flexible purchasing models, such as leasing, can also mitigate cost barriers, enhancing accessibility in resource-limited settings. The market's nature is dynamic, underscored by rapid technological advancements and shifting healthcare landscapes, necessitating continuous adaptation to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Biopsy Device Market

The Breast Biopsy Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing cases of breast cancer across the world
  • Government initiative for awareness and treatment of breast cancer
  • Shifting preferences for early detection and screening for breast cancer
• Market Restraints
  • Possibilities of infection associated with biopsy needles
• Market Opportunities
  • Advent of liquid biopsy devices for breast cancer treatment
  • On-going clinical trial and increase in new product development
• Market Challenges
  • Dearth of financial and technical resources

Porter's Five Forces: A Strategic Tool for Navigating the Breast Biopsy Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Biopsy Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Biopsy Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Biopsy Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Biopsy Device Market

A detailed market share analysis in the Breast Biopsy Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Biopsy Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Biopsy Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Biopsy Device Market

A strategic analysis of the Breast Biopsy Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Biopsy Device Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Group Incorporated, Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Halma plc, Hologic, Inc, INRAD Inc., Medline Industries, LP, Medtronic PLC, Merit Medical Systems, Inc., Ningbo Xinwell Medical Technology Co., LTD., PAJUNK GmbH, Planmeca Oy, Point Blank Medical, Siemens Healthcare GmbH, SNVL Varay Laborix, STERYLAB S.r.l., Suretech Medical Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, Vector Medical, Inc., and Zamar Care.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biopsy Needles, Biopsy Tables, Guidance Systems, and Localization Wires.
• Based on Test, market is studied across Needle Breast Biopsy and Surgical Biopsy. The Needle Breast Biopsy is further studied across Core-Needle Aspiration, Fine-Needle Aspiration, and Vacuum-Assisted Core Biopsy. The Surgical Biopsy is further studied across Excisional Breast Biopsy and Incisional Breast Biopsy.
• Based on Guidance, market is studied across Magnetic Resonance-Guided, Mammography-Guided Stereotactic, and Ultrasound-Guided.
• Based on End-Use, market is studied across Diagnostic Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing cases of breast cancer across the world
    • 5.1.1.2. Government initiative for awareness and treatment of breast cancer
    • 5.1.1.3. Shifting preferences for early detection and screening for breast cancer
  • 5.1.2. Restraints
    • 5.1.2.1. Possibilities of infection associated with biopsy needles
  • 5.1.3. Opportunities
    • 5.1.3.1. Advent of liquid biopsy devices for breast cancer treatment
    • 5.1.3.2. On-going clinical trial and increase in new product development
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of financial and technical resources
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Breast Biopsy Device Market, by Product

• 6.1. Introduction
• 6.2. Biopsy Needles
• 6.3. Biopsy Tables
• 6.4. Guidance Systems
• 6.5. Localization Wires

7. Breast Biopsy Device Market, by Test

• 7.1. Introduction
• 7.2. Needle Breast Biopsy
  • 7.2.1. Core-Needle Aspiration
  • 7.2.2. Fine-Needle Aspiration
  • 7.2.3. Vacuum-Assisted Core Biopsy
• 7.3. Surgical Biopsy
  • 7.3.1. Excisional Breast Biopsy
  • 7.3.2. Incisional Breast Biopsy

8. Breast Biopsy Device Market, by Guidance

• 8.1. Introduction
• 8.2. Magnetic Resonance-Guided
• 8.3. Mammography-Guided Stereotactic
• 8.4. Ultrasound-Guided

9. Breast Biopsy Device Market, by End-Use

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Hospitals & Clinics

10. Americas Breast Biopsy Device Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Breast Biopsy Device Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Breast Biopsy Device Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advin Health Care
• 2. Argon Medical Devices, Inc.
• 3. Becton, Dickinson and Company
• 4. Cook Group Incorporated
• 5. Danaher Corporation
• 6. FUJIFILM Corporation
• 7. GE HealthCare Technologies Inc.
• 8. Halma plc
• 9. Hologic, Inc
• 10. INRAD Inc.
• 11. Medline Industries, LP
• 12. Medtronic PLC
• 13. Merit Medical Systems, Inc.
• 14. Ningbo Xinwell Medical Technology Co., LTD.
• 15. PAJUNK GmbH
• 16. Planmeca Oy
• 17. Point Blank Medical
• 18. Siemens Healthcare GmbH
• 19. SNVL Varay Laborix
• 20. STERYLAB S.r.l.
• 21. Suretech Medical Inc.
• 22. Thermo Fisher Scientific Inc.
• 23. Trivitron Healthcare
• 24. Vector Medical, Inc.
• 25. Zamar Care